Toll-like receptor signaling pathway in sepsis

Central-European Journal of Immunology

Volumn 34, Issue 2, 2009, Pages 124-128

  Słotwiński, Robert ^a,b   Słotwińska, Sylwia M ^a   Bałan, Barbara J ^a   Kedziora, Sylwia ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Sepsis; Signaling pathway; Toll like receptors

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

BACTERIAL IMMUNITY; BINDING AFFINITY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PROTEIN CARBOHYDRATE INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSCRIPTION INITIATION;

EID: 70349631374     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Linde-Zwirble WT, Angus DC (2004): Severe sepsis epidemiology: sampling, selection, and society. Crit Care 8: 222-226
2. Bernard GR, Vincent J-L, Laterre PF et al. (2001): Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709.
3. Alberti C, Brun-Buisson C, Goodman SV et al. (2003): Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168: 77-84.
4. Zieliński A, Czarkowski MP (2004): Choroby zakaźne w Polsce w 2002 roku. Przegl Epidemiol 58: 9-19.
5. Imahara SD, O'Keefe GE (2004): Genetic determinants of the inflammatory response. Curr Opin Crit Care 10: 318-324.
6. Hotchkiss RS, Karl IE (2003): The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150.
7. Riedemann NC, Guo R-F, Ward PA (2003): Novel strategies for the treatment of sepsis. Nature Medicine 9: 517-524.
8. Akira S, Uematsu S, Takeuchi O (2006): Pathogen Recognition and Innate Immunity. Cell 124: 783-801.
9. Kaisho T, Akira S (2006): Toll-like receptor function and signaling. J Allergy Clin Immunol 117: 979-987.
10. Takeda K, Akira S (2005): Toll-like receptors in innate immunity. Immunol 17: 1-14.
11. Akira S, Takeda K (2004): Toll-like receptors signaling. Nat Rev Immunol 5: 987-995.
12. Kawai T, Akira S (2006): TLR signaling. Cell Death Differ 13: 816-825.
13. Biswas SK, Tergaonkar V (2007): Myleoid differentiation factor 88-independent Toll-like receptor pathway: Sustaining inflammation or promoting tolerance? Int J Biochem Cell Biol 39: 1582-1592.
14. Yamamoto M, Takeda K, Akira S (2004): TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol 40: 861-868.
15. Zhang G, Ghosh S (2002): Negative regulation of Toll-like receptor-mediatewd signaling by Tollip. J Biol Chem 277: 7059-7065.
16. Divanovic S, Trompette A, Atabani SF et al. (2005): Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 6: 571-578.
17. Qin J, Qian Y, Yao J et al. (2005): SIGIRR inhibits interleukin-1 receptor- and Toll-like receptor 4-mediated signaling through different mechanisms. J Biol Chem 80: 25233-25241.
18. Brint EK, Xu D, Liu H et al. (2004): ST2 is an inhibitor of interleukin-1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat-Immunol 5: 373-379.
19. Burns K, Janssens S, Brissoni B et al. (2003): Inhibition of interleukin-1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK- 4. J Exp Med 197: 263-268.
20. Choi KC, Lee YS, Lim S et al. (2006): Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 7: 1057-1065.
21. Hoebe K, Du X, Goergel P et al. (2003): Identification of Lps2 as a key transducer of MyD88- independent TIR signaling. Nature 424: 743-748.
22. Kawai T, Adachi O, Ogawa T et al. (1999): Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
23. Yamamoto M, Sato S, Mori K et al. (2002): A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-b promoter in the Toll-like receptor signaling. J Immunol 169: 6668-6672.
24. Yamamoto M, Sato S, Hemmi H et al. (2003): Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301: 640-643.
25. Takeuchi O, Takeda K, Hoshino K et al. (2000): Cellular responses to bacterial cell wall components are mediated through MyD88-dependentsignaling cascades. Int Immunol 12: 113-117.
26. Weighardt H, Kaiser-Moore S, Vabulas RM et al. (2002): Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J Immunol 169: 2823-2827.
27. Feterowski C, Mack M, Weighardt H et al. (2004): CC chemokine receptor 2 regulates leukocyte recruitment and 10 production during acute polymicrobial sepsis. Eur J Immunol 34: 3664-3673.
28. Weighardt H, Mages J, Jusek G et al. (2006): Organ-specific role of MyD88 for gene regulation during polymicrobial peritonitis. Infect Immun 74: 3618-3632.
29. Covert MW, Leung TH, Gaston JE et al. (2005): Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309: 1854-1857.
30. Kamochi M, Kamochi F, Kim YB et al. (1999): P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment, and injury to the lung and liver. Am J Physiol 277: L310-L319.
31. Raeburn CD, Calkins CM, Zimmerman MA et al. (2001): Vascular cell adhesion molecule-1 expression is obligatory for endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction. Surgery 130: 319-325.
32. Kumasaka T, Quinlan WM, Doyle NA et al. (1996): Role of intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest 97: 2362-2369.
33. Matsuda N, Yamazaki H, Takano K et al. (2008): Priming by lipopolysaccharide exaggerates acute lung injury and mortality in responses to peptidoglycan through up-regulation of Toll-like receptor-2 expression in mice. Biochemical Pharmacology 75: 1065-1075.
34. Carneiro LAM, Travassos LH, Philpott DJ (2004): Innate immune recognition of microbes through Nod1 and Nod2: implications for disease. Microbes Infect 6: 609-616
35. Sońdka Z, Tretyn A, Szeliga J et al. (2006): Udzial białek zawierajacych powtórzenia bogate w leucyne (LLR) w molekularnych mechanizmach odporności wrodzonej roślin i zwierzat. Post Biol Kom 33: 635-655.
36. Chamaillard M, Hashimoto M, Horie Y et al. (2003): An essential role for Nod1 in host recognition of bacterial peptidoglykan containing diaminopimelic acid. Nat Immunol 3: 702-707.
37. Girardin SE, Boneca IG, Viala J et al. (2003): Nod2 is a general sensor of peptidoglykan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869-8872.
38. Inohora N, Nunez G (2003): NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3: 371-382.
39. Hugot JP, Chamaillard M, Zouali H et al. (2001): Association of-NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
40. Colonn M, Facchetti F (2003): TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory response. J Infect Dis 187 (Suppl 2): S397-S401.
41. Gibot S, Kolopp-Sarda MN, Bene MC et al. (2004): Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141: 9-15.
42. Bustin M (1999): Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19: 5237-5246.
43. Wang H, Yang H, Czura CJ et al. (2001): HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 164: 1768-1773.
44. Sha Y, Zmijewski J, Xu Z et al. (2008): HMGB1 Developes enhanced proinflammatory activity by binding to cytokines. J Immunol 180: 2531-2537.
45. El Gazzar M (2007): HMGB1 modulates inflammatory responses in LPS-activated macrophages. Inflamm Res 56: 162-167.
46. Wang H, Bloom O, Zhang M et al. (1999): HMGB-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
47. Yang H (2004): Reversing established sepsis with antagonists of endogenous high mobility group box 1. Proc Natl Acad Sci USA 101: 296-301.
48. Park JS, Svetkauskaite D, He Q et al. (2004): Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279: 7370-7377.
49. Park JS, Arcaroli J, Yum HK et al. (2003): Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 284: C870-C879.
50. Silva E, Arcaroli J, Oianbin He et al. (2007): HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury. Intensive Care Med 33: 1829-1839.
51. Matthay MA, Ware LB (2004): Can nicotine treat sepsis? Nat Med 10: 1161-1162.
52. Khaleda RQ, Wulf O, Mahavir S et al. (2007): Microbial heat shock protein 70 stimulatory properties have different TLR requirements. Vaccine 25: 1096-1103.
53. Wischmeyer PE, Kahana MD, Wolfson R et al. (2001): Glutamine induces heat shock protein and protects against endotoxin shock in the rat. Journal of Applied Physiology 90: 2403-2410.
54. Wischmeyer PE, Musch MW, Madonna MB et al. (1997): Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol 272: G879-G884.
55. Wischmeyer PE (2002): Glutamine and heat shock protein expression. Nutrition 18: 225-228.
56. Tsung A, Zheng N, Jeyabalan G et al. (2007): Increasing numbers of hepatic dendritic cells promote HMGB1 mediated ischemia-reperfusion injury. J Leukoc Biol 81: 119-128.